Literature DB >> 7616540

Duchenne muscular dystrophy: negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X linked incomplete congenital stationary night blindness.

H Jensen1, M Warburg, O Sjö, M Schwartz.   

Abstract

Aland Island eye disease (AIED) and X linked congenital stationary night blindness (CSNB) have been mapped to Xp11.3. Patients have been described with deletions of the Duchenne muscular dystrophy (DMD) gene who also had a negative electroretinogram (ERG) similar to that seen in patients with CSNB and AIED. This seems to confirm that some cases of AIED and CSNB map to Xp21. We examined 16 boys with DMD/BMD (Becker muscular dystrophy) of whom 10 had negative ERGs, eight of them having deletions downstream from exon 44. Normal dark adaptation thresholds were observed in all patients and there were no anomalous visual functions. Hence, CSNB cannot be assigned to Xp21 and negative ERG in DMD/BMD is not associated with eye disease. Six boys with DMD/BMD had normal ERGs. We speculate that a retinal or glial dystrophin may be truncated or absent in the boys with negative ERGs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616540      PMCID: PMC1050428          DOI: 10.1136/jmg.32.5.348

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  [A NEW EYE SYNDROME WITH X-CHROMOSOMAL TRANSMISSION. A FAMILY CLAN WITH FUNDUS ALBINISM, FOVEA HYPOPLASIA, NYSTAGMUS, MYOPIA, ASTIGMATISM AND DYSCHROMATOPSIA].

Authors:  H FORSIUS; A W ERIKSSON
Journal:  Klin Monbl Augenheilkd       Date:  1964-04       Impact factor: 0.700

2.  A locus for X-linked congenital stationary night blindness is located on the proximal portion of the short arm of the X chromosome.

Authors:  N T Bech-Hansen; L L Field; A M Schramm; M Reedyk; I W Craig; N J Fraser; W G Pearce
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

3.  [X-chromosomal hereditary night blindness: detection of carriers by segregation analysis with linked DNA markers].

Authors:  U Orth; A Schinzel; M Mächler; A Gal
Journal:  Klin Monbl Augenheilkd       Date:  1990-05       Impact factor: 0.700

4.  Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3.

Authors:  M A Musarella; R G Weleber; W H Murphey; R S Young; L Anson-Cartwright; M Mets; S P Kraft; R Polemeno; M Litt; R G Worton
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

5.  Standard for clinical electroretinography. International Standardization Committee.

Authors: 
Journal:  Arch Ophthalmol       Date:  1989-06

6.  Deletion mapping of Aland Island eye disease to Xp21 between DXS67 (B24) and Duchenne muscular dystrophy.

Authors:  D A Pillers; J A Towbin; J S Chamberlain; D Wu; J Ranier; B R Powell; E R McCabe
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

7.  Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction.

Authors:  A H Beggs; M Koenig; F M Boyce; L M Kunkel
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

8.  Aland Island eye disease (Forsius-Eriksson ocular albinism) and an Xp21 deletion in a patient with Duchenne muscular dystrophy, glycerol kinase deficiency, and congenital adrenal hypoplasia.

Authors:  D A Pillers; R G Weleber; B R Powell; C E Hanna; R E Magenis; N R Buist
Journal:  Am J Med Genet       Date:  1990-05

Review 9.  Aland Island eye disease (Forsius-Eriksson syndrome) associated with contiguous deletion syndrome at Xp21. Similarity to incomplete congenital stationary night blindness.

Authors:  R G Weleber; D A Pillers; B R Powell; C E Hanna; R E Magenis; N R Buist
Journal:  Arch Ophthalmol       Date:  1989-08

10.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

View more
  7 in total

1.  The negative ERG is not synonymous with nightblindness.

Authors:  G W Cibis; K M Fitzgerald
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.

Authors:  K M Fitzgerald; G W Cibis; A H Gettel; R Rinaldi; D J Harris; R A White
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

3.  Unilateral negative electroretinogram presenting as photophobia.

Authors:  Ai Kido; Ken Ogino; Yozo Miyake; Kazuo Yanagida; Takanobu Kikuchi; Nagahisa Yoshimura
Journal:  Doc Ophthalmol       Date:  2016-05-31       Impact factor: 2.379

4.  The incidence of negative ERG in clinical practice.

Authors:  A H Koh; C R Hogg; G E Holder
Journal:  Doc Ophthalmol       Date:  2001-01       Impact factor: 2.379

5.  Negative scotopic ERG and photopic ERG ON response impairment in a patient with normal dark adaptation.

Authors:  Naoyuki Tanimoto; Tomoaki Usui; Mikio Ichibe; Manami Kuze; Mineo Takagi; Shigeru Hasegawa; Masahisa Sato; Keiko Tanaka; Haruki Abe
Journal:  Doc Ophthalmol       Date:  2006-10-12       Impact factor: 2.379

6.  Two cases of unilateral cone-rod dysfunction with negative electroretinograms.

Authors:  Kenji Ozawa; Shunsuke Takahashi; Kiyofumi Mochizuki; Yozo Miyake
Journal:  Doc Ophthalmol       Date:  2019-08-02       Impact factor: 2.379

7.  Verifying complaints of difficulties in night vision using electroretinography and dark adaptation tests.

Authors:  Gilad Allon; Yolanda Friedrich; Eedy Mezer; Aviran Itzhaki; Rina Leibu; Ido Perlman
Journal:  Doc Ophthalmol       Date:  2019-10-16       Impact factor: 2.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.